TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean postoperative BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean postoperative HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fecal propionate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CHIP prevalence in SLE patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Oswestry Disability Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conductive hearing loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient comfort regarding heaviness and hearing gain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants suffering cardiovascular disease events
Endpoint domain: Adverse events/effects
Primary endpoint: Average health scores at 5 years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total 5-year household cost per beneficial health outcome
Endpoint domain: Resource use
Primary endpoint: Symptom perception scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SCHFI management scores
Endpoint domain: Life impact
Endpoint subdomain: Self-care management
Primary endpoint: Quality-adjusted life-years
Endpoint domain: Resource use
Primary endpoint: Unintended pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Uhep/UCr concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative dose of PCA analgesics required after 24 hours postsurgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in mechanical nociceptive threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolic deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nerve root injury
Endpoint domain: Adverse events/effects
Primary endpoint: Peri-implant clinical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary TNFα levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OS dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEGF expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stigma reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in inflammation markers (leptin, resistin, MCP‐1, IL‐6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in total cholesterol (TC) and increase in HDL cholesterol (HDL-c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improved nephrology-specific clinical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional exhaled nitric oxide (Feno) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression scores (TGDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in stress scores (DASS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cementation quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Cholesterol/HDL-C Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Generalized anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social-distancing intentions
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: SCal level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suicidal ideation severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotion regulation difficulties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDM uptake
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: ST-segment resolution (>50%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum CK, creatine kinase-MB fraction, and troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete lysis of VT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of complications at the puncture site
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious adverse events requiring hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of confirmed hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of genital infections
Endpoint domain: Adverse events/effects
Primary endpoint: MMAS-8 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life related to mental states
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Learning ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Short-term verbal memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to dissociate from ECMO circuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to re-establish ECMO support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: APS T-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rates of treatment at 3 and 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total TCM syndrome scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of ALB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: frequency of poor and restless sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: MWPC for WOMAC domains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: induced pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: induced pain area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum plasma concentration (AUC0–t and AUC0–∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Posturographic parameters (CoP sway area, CoP path length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durations of TUGT and FSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unipedal stance time, SSQ and MoCA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful debridement, antibiotics, irrigation and retention of prosthesis therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate ratios of hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of satisfaction assessed using the ITSQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correlation between IPAQ-SF and PASE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of PASE compared to IPAQ-SF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement error in IPAQ-SF and PASE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean office BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average cSBP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients achieving normal office BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Depression criteria met
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DFU wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with a hospital encounter
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Median overall postoperative visit time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TB incidence reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microstate C proportion and occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Return ED visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Urticaria activity score summed up over 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgA, IgG, and CD4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-reported internalising symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported externalising symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miPSMA expression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional toll on home care clients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for family/friend caregiver support
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete response at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-free survival at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Success rate of nail placements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average X-ray exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screw penetration rates
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue texture and color match
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global severity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hope for the future
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct rejection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grooved pegboard test completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Archery score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic ischemic strokes and systemic embolic events
Endpoint domain: Mortality/survival
Primary endpoint: NRS sleep scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: RVMi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RVEDVi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RVESVi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Platelet reactivity unit (PRU) at 4 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with moderate or severe angiographic quantitative AR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean angiographic quantitative AR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AUCs of PSO17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 17O fractions calculated from MRI signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumour NK-cell infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of EA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients requiring a jaw thrust during intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improper infection control practices
Endpoint domain: Adverse events/effects
Primary endpoint: Positive explicit attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ΔAVC (change in aortic valve calcification score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary lactulose/mannitol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Urine-to-milk-lactulose/lactose ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visits to psychologists/psychotherapists
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Collaborative care measures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Received cognitive behavioural therapy (CBT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: increased motor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Weekly migraine headache day reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy scores of continuous walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: postoperative health scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LNG AUC0-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LNG AUC0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stereo acuity measured with the Titmus test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkour time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkour error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to CKD stage 4
Endpoint domain: Mortality/survival
Primary endpoint: BMD gains over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: liver-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: progression to CTP C cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Tei Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma PC-DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC total DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma enrichment of d3-PC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from imaging to groin puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from hospital admission to stroke imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent reduction of IL-8/IL-10 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall treatment success at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of at least 2-grade improvement in psoriasis signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stopped per rectal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSID-III cognitive development scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSID-III motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delta L* value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: RNFL reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TRT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ONHV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative fentanyl consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 10-year survival free of cardiorespiratory deterioration
Endpoint domain: Mortality/survival
Primary endpoint: scores on multiple-choice test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of menstrual pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic consumption difference
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: acute renal injury prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urinary magnesium and potassium loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: long-term generalization learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat Free Mass (FFM) estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean Soft Tissue Mass (LSTM) estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dyspnea severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPSS questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average positional change of IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Peak aerobic power (peak pulmonary O2 uptake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General health and vitality (SF36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: triglyceride (TG) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BCTOS cosmesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCTOS pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACT‐B Emotional Well‐being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: enhancement of secondary prevention of cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: wmCFB in 0-24-h FEV1 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: trough FEV1 CFB at Day 84 and 85
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Health risk behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Network structure and global strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modifications in disc and condyle positions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of the presence of JE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death within one year
Endpoint domain: Mortality/survival
Primary endpoint: Composite of MACCE within one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of children using CRS in the rear row
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children aged 12-17 using seat belts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation failure within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: composite CVD outcome
Endpoint domain: Mortality/survival
Primary endpoint: coronary artery disease events
Endpoint domain: Mortality/survival
Primary endpoint: cerebrovascular accidents (stroke)
Endpoint domain: Mortality/survival
Primary endpoint: average diagnostic sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: average specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: overall average detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: self-efficacy for progressive muscle relaxation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RmVO2 (Resting muscle oxygen consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes